US FDA’s Patient Input Guidance Opens Door Wider To Social Media Data Collection
Executive Summary
Following stakeholder criticism of an earlier discussion paper, draft guidance does not automatically foreclose use of social media data as the primary source of qualitative research; however, agency says entities submitting such data for regulatory review must ensure rigor in methodology and data integrity.
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
